The radial distance of extraprostatic extension of prostatic adenocarcinoma: Implications for prostate brachytherapy

[1]  D. Bostwick,et al.  Influence of prostate-specific antigen testing on the spectrum of patients with prostate cancer undergoing radical prostatectomy at a large referral practice. , 1998, Mayo Clinic proceedings.

[2]  R. Stock,et al.  A dose-response study for I-125 prostate implants. , 1998, International journal of radiation oncology, biology, physics.

[3]  A. Pollack,et al.  External beam radiotherapy for stage T1/T2 prostate cancer: how does it stack up? , 1998, Urology.

[4]  D. Bostwick,et al.  Anatomic site-specific positive margins in organ-confined prostate cancer and its impact on outcome after radical prostatectomy. , 1997, Urology.

[5]  R. Millikan,et al.  Update of the NCCN guidelines for treatment of prostate cancer. , 1997, Oncology.

[6]  J. Blasko,et al.  Interstitial iodine‐125 radiation without adjuvant therapy in the treatment of clinically localized prostate carcinoma , 1997, Cancer.

[7]  A. Hanlon,et al.  Conformai external beam treatment of prostate cancer , 1997 .

[8]  M. Zelefsky,et al.  Long-term results of retropubic permanent 125iodine implantation of the prostate for clinically localized prostatic cancer. , 1997, The Journal of urology.

[9]  A. Schned,et al.  Tissue-shrinkage correction factor in the calculation of prostate cancer volume. , 1996, The American journal of surgical pathology.

[10]  D. Bostwick,et al.  Correlation of pretherapy prostate cancer characteristics with seminal vesicle invasion in radical prostatectomy specimens. , 1996, International journal of radiation oncology, biology, physics.

[11]  K. Wallner,et al.  103Pd brachytherapy and external beam irradiation for clinically localized, high-risk prostatic carcinoma. , 1996, International journal of radiation oncology, biology, physics.

[12]  P. Unger,et al.  Prostate specific antigen findings and biopsy results following interactive ultrasound guided transperineal brachytherapy for early stage prostate carcinoma , 1996, Cancer.

[13]  D. Bostwick,et al.  Prediction of capsular perforation and seminal vesicle invasion in prostate cancer. , 1996, The Journal of urology.

[14]  J Roy,et al.  Tumor control and morbidity following transperineal iodine 125 implantation for stage T1/T2 prostatic carcinoma. , 1996, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[15]  J. Blasko,et al.  Prostate specific antigen based disease control following ultrasound guided 125iodine implantation for stage T1/T2 prostatic carcinoma. , 1995, The Journal of urology.

[16]  L. Verhey,et al.  The value of nonuniform margins for six-field conformal irradiation of localized prostate cancer. , 1995, International journal of radiation oncology, biology, physics.

[17]  Ravinder Nath,et al.  Dosimetry of interstitial brachytherapy sources: Recommendations of the AAPM Radiation Therapy Committee Task Group No. 43 , 1995 .

[18]  J E Oesterling,et al.  PSA and staging of localized prostate cancer. , 1993, The Urologic clinics of North America.

[19]  A W Partin,et al.  Serum PSA after anatomic radical prostatectomy. The Johns Hopkins experience after 10 years. , 1993, The Urologic clinics of North America.

[20]  C. Ling,et al.  Modeling the development of metastases from primary and locally recurrent tumors: comparison with a clinical data base for prostatic cancer. , 1993, Cancer research.

[21]  P. Walsh,et al.  Influence of capsular penetration on progression following radical prostatectomy: a study of 196 cases with long-term followup. , 1993, The Journal of urology.

[22]  P. Scardino,et al.  Frequency and location of extracapsular extension and positive surgical margins in radical prostatectomy specimens. , 1992, The Journal of urology.

[23]  R. B. Smith,et al.  Prostate specific antigen levels after radical prostatectomy in patients with organ confined and locally extensive prostate cancer. , 1992, The Journal of urology.

[24]  C B Begg,et al.  The effect of local control on metastatic dissemination in carcinoma of the prostate: long-term results in patients treated with 125I implantation. , 1991, International journal of radiation oncology, biology, physics.

[25]  J. Oesterling,et al.  Predicting radionuclide bone scan findings in patients with newly diagnosed, untreated prostate cancer: prostate specific antigen is superior to all other clinical parameters. , 1991, The Journal of urology.

[26]  J. Moul,et al.  Radical prostatectomy for clinical stage T1-2N0M0 prostatic adenocarcinoma: long-term results. , 1990, The Journal of urology.

[27]  W. Catalona,et al.  Nerve-sparing radical prostatectomy: evaluation of results after 250 patients. , 1990, The Journal of urology.

[28]  T. Stamey,et al.  Morphometric and clinical studies on 68 consecutive radical prostatectomies. , 1988, The Journal of urology.

[29]  J. Hendriks,et al.  Histologic multifocality of tis, T1–2 breast carcinomas implications for clinical trials of breast‐conserving surgery , 1985, Cancer.

[30]  A. Harwood.  Conventional fractionated radiotherapy for 51 patients with lentigo maligna and lentigo maligna melanoma. , 1983, International journal of radiation oncology, biology, physics.

[31]  Fred H. Hochberg,et al.  Assumptions in the radiotherapy of glioblastoma , 1980, Neurology.

[32]  A. Breslow,et al.  Optimal size of resection margin for thin cutaneous melanoma. , 1977, Surgery, gynecology & obstetrics.

[33]  J. Battermann,et al.  494Loss of I-125 seeds after perineal implantation of the prostate , 1996 .

[34]  D. Bostwick,et al.  Correlation of pretherapy prostate cancer characteristics with histologic findings from pelvic lymphadenectomy specimens. , 1996, International Journal of Radiation Oncology, Biology, Physics.

[35]  S Nag,et al.  Transperineal palladium 103 prostate brachytherapy: analysis of morbidity and seed migration. , 1995, Urology.

[36]  P. Canoll,et al.  1020 Using pre-treatment PSA and gleason score to predict for extra capsular extension among patients with clinically staged organ confined prostate cancer , 1995 .

[37]  R Mohan,et al.  Three-dimensional conformal radiation therapy in locally advanced carcinoma of the prostate: preliminary results of a phase I dose-escalation study. , 1994, International journal of radiation oncology, biology, physics.

[38]  D. Bostwick,et al.  Staging of prostate cancer. , 1994, Seminars in surgical oncology.

[39]  A. Martinez,et al.  Improved local control and survival for surgically staged patients with locally advanced prostate cancer treated with up-front low dose rate iridium-192 prostate implantation and external beam irradiation. , 1994, International journal of radiation oncology, biology, physics.